GNS561

· Genfit

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GNS561, covering 2021-07-28 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma [Phase 1, Phase 2]